(Q80316397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Schwemmlein M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stieglmaier J

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Kellner C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Peipp M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Saul D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Oduncu F

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Emmerich B

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Stockmeyer B

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lang P

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Beck JD

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fey GH

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

10 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1405-1412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17495978%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404687

30 December 2019

exact match

0 references

cites work

Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

In vitro and in vivo antitumor activity of a chimeric anti-CD19 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

The mechanisms of action of rituximab in the elimination of tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Clinical experience with CD3 x CD19 bispecific antibodies in patients with B cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Bispecific antibodies targeting cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3- bispecific single-chain antibody construct

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Clonal analysis of a human antimouse antibody (HAMA) response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Characterization of acute lymphoblastic leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404687

7 January 2021